Meghan Gage Selected Research

Isoflurophate (DFP)

1/2022	DFP-Induced Status Epilepticus Severity in Mixed-Sex Cohorts of Adult Rats Housed in the Same Room: Behavioral and EEG Comparisons.
1/2022	Characterization of Cortical Glial Scars in the Diisopropylfluorophosphate (DFP) Rat Model of Epilepsy.
12/2021	Saracatinib, a Src Tyrosine Kinase Inhibitor, as a Disease Modifier in the Rat DFP Model: Sex Differences, Neurobehavior, Gliosis, Neurodegeneration, and Nitro-Oxidative Stress.
1/2021	Differential Impact of Severity and Duration of Status Epilepticus, Medical Countermeasures, and a Disease-Modifier, Saracatinib, on Brain Regions in the Rat Diisopropylfluorophosphate Model.
11/2020	Diapocynin, an NADPH oxidase inhibitor, counteracts diisopropylfluorophosphate-induced long-term neurotoxicity in the rat model.
11/2020	Sex as a biological variable in the rat model of diisopropylfluorophosphate-induced long-term neurotoxicity.
1/2020	Inducible nitric oxide synthase inhibitor, 1400W, mitigates DFP-induced long-term neurotoxicity in the rat model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Meghan Gage Research Topics

Disease

8	Status Epilepticus (Complex Partial Status Epilepticus) 01/2022 - 01/2020
6	Gliosis 01/2022 - 01/2020
5	Seizures (Absence Seizure) 01/2022 - 01/2020
2	Brain Injuries (Brain Injury) 01/2021 - 01/2020
1	Epilepsy (Aura) 01/2022
1	Cicatrix (Scar) 01/2022

Drug/Important Bio-Agent (IBA)

7	Isoflurophate (DFP)FDA Link 01/2022 - 01/2020
4	OrganophosphatesIBA 01/2022 - 11/2020
3	Nerve AgentsIBA 01/2022 - 01/2021
2	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 01/2022 - 12/2021
2	3-nitrotyrosineIBA 12/2021 - 01/2020
2	saracatinibIBA 12/2021 - 01/2021
2	Diazepam (Valium)FDA LinkGeneric 01/2021 - 01/2020
2	Atropine FDA LinkGeneric 01/2021 - 01/2020
2	OximesIBA 01/2021 - 01/2020
2	Cholinergic Agents (Cholinergics)IBA 01/2021 - 11/2020
2	CytokinesIBA 11/2020 - 01/2020
2	ChemokinesIBA 11/2020 - 01/2020
1	Complement C3 (C3 Complement)IBA 01/2022
1	Chondroitin Sulfate ProteoglycansIBA 01/2022
1	src-Family KinasesIBA 12/2021
1	Anticonvulsants (Antiepileptic Drugs)IBA 01/2021
1	Proto-Oncogene Proteins c-fynIBA 01/2021
1	SomanIBA 01/2021
1	Midazolam (Versed)FDA LinkGeneric 01/2021
1	Interleukin-17 (Interleukin 17)IBA 11/2020
1	LeptinIBA 11/2020
1	Blood Proteins (Serum Proteins)IBA 11/2020
1	NitritesIBA 11/2020
1	Interleukin-6 (Interleukin 6)IBA 11/2020
1	InterleukinsIBA 11/2020
1	Interleukin-2 (IL2)IBA 11/2020
1	AcetylcholinesteraseIBA 11/2020

Therapy/Procedure

1	Therapeutics 01/2020